Ignite Creation Date:
2024-05-06 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05178511
Status:
RECRUITING
Last Update Posted:
2022-01-05
First Post:
2021-12-02
Brief Title:
Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance
Sponsor:
Organization:
Sun Yat-sen University